Increased Id1 and Id3 expression is observed in multiple cancers and predicts a poor prognosis, including breast cancer, prostate cancer, colorectal cancer, et al. Although Id1 and Id3 are reported compensatory in the mouse model 23, several studies believe that Id1 and Id3 could have distinct pathways 24. This evidence concerns the gene ID3 and prostate cancer.